NAD-ME Antikörper
Kurzübersicht für NAD-ME Antikörper (ABIN7003513)
Target
Alle NAD-ME Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Produktmerkmale
- Polyclonal Antibody
-
Aufreinigung
- Antigen affinity purification
-
Immunogen
- Synthetic peptide of human ME2
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB 1:500-1:2000, ELISA 1:5000-1:10000
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.78 mg/mL
-
Buffer
- PBS with 0.05 % Sodium azide and 40 % Glycerol, pH 7.4
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- NAD-ME (NAD Dependent Malate Dehydrogenase (NAD-ME))
-
Andere Bezeichnung
- ME2
-
Hintergrund
- This gene encodes a mitochondrial NAD-dependent malic enzyme, a homotetrameric protein, that catalyzes the oxidative decarboxylation of malate to pyruvate. It had previously been weakly linked to a syndrome known as Friedreich ataxia that has since been shown to be the result of mutation in a completely different gene. Certain single-nucleotide polymorphism haplotypes of this gene have been shown to increase the risk for idiopathic generalized epilepsy. Alternatively spliced transcript variants encoding different isoforms found for this gene.
-
Molekulargewicht
-
Observed_MW: Refer to figures
Calculated_MW: 65 kDa
-
UniProt
- P23368
-
Pathways
- Production of Molecular Mediator of Immune Response
Target
-